Transmembrane protein 177 (TMEM177) is a protein that in humans is encoded by the TMEM177 gene . TMEM177 is involved in the COX2 biogenesis pathway . Although TMEM177 is not required for cytochrome c oxidase activity, its quantity is directly related to COX20 abundance . TMEM177 is an integral membrane protein .
Role in Cytochrome c Oxidase Assembly: TMEM177 plays a role in the early stages of cytochrome c oxidase subunit II (MT-CO2/COX2) maturation and is needed to stabilize COX20 and newly synthesized COX2 .
Interaction with COX20: TMEM177 associates with newly synthesized COX2 and SCO2 in a COX20-dependent manner . Disturbing the balance of TMEM177 leads to the accumulation of newly synthesized COX2 in a COX20-associated state . TMEM177 promotes the assembly of COX2 at the CuA-site formation level .
TMEM176B in GC Cells: Overexpression of TMEM176B in gastric cancer (GC) cells increases cell proliferation, migration, and invasion, while inhibiting apoptosis .
Amino Acid Metabolism: TMEM176B regulates amino acid metabolism through the PI3K-Akt-mTOR signaling pathway and promotes gastric cancer progression .
*Prediction of transmembrane spans of TMEM177 can be performed using TMpred . Mitochondrial targeting sequence can be predicted by MitoProt Server .
Recombinant Mouse Transmembrane protein 177 (Tmem177) plays a crucial role in the early stages of cytochrome c oxidase subunit II (MT-CO2/COX2) maturation. It is essential for the stabilization of COX20 and the newly synthesized MT-CO2/COX2 protein.
Mouse TMEM177 is a 311-amino acid transmembrane protein with a molecular weight of approximately 34.1 kDa. It contains multiple transmembrane spans that anchor it within the inner mitochondrial membrane. The complete amino acid sequence begins with MAGPLWRAAA and continues through a series of hydrophobic and hydrophilic regions that form its characteristic membrane-spanning domains . Bioinformatic analysis using tools like TMpred identifies several transmembrane domains that are essential for its localization and function within the mitochondrial membrane. The protein likely includes a mitochondrial targeting sequence that directs its import into mitochondria after cytosolic synthesis .
TMEM177 primarily functions in the early steps of cytochrome c oxidase subunit II (MT-CO2/COX2) maturation. It serves as a critical stabilizing factor for both COX20 (a scaffold protein) and newly synthesized COX2 protein . Research has demonstrated that TMEM177 forms a complex with COX2 and copper chaperones, suggesting its involvement in the copper delivery pathway to the Cu A-site of COX2. While TMEM177 is dispensable for cytochrome c oxidase activity under normal conditions, its abundance directly influences COX20 levels, indicating its regulatory role in the assembly process . By promoting COX2 assembly at the level of Cu A-site formation, TMEM177 contributes to the proper assembly of the cytochrome c oxidase complex, a key component of the mitochondrial respiratory chain .
While comprehensive tissue-specific expression profiles for mouse TMEM177 are still emerging in the scientific literature, it is expected to follow patterns typical of proteins involved in mitochondrial respiration. As a protein involved in respiratory chain complex assembly, its expression is likely regulated in coordination with other proteins involved in oxidative phosphorylation and mitochondrial biogenesis. Based on the function of TMEM177 in mitochondrial processes, tissues with high energy demands such as heart, brain, and skeletal muscle would be expected to exhibit higher expression levels . In zebrafish models, tmem177 has been identified as a protein-coding gene on chromosome 9, further supporting its conservation and importance across vertebrate species .
TMEM177 has been identified as a constituent of the COX20 interaction network through quantitative mass spectrometry studies. This interaction is functionally significant, as changes in TMEM177 levels directly affect COX20 abundance - when TMEM177 is depleted, COX20 levels decrease; conversely, when TMEM177 is overexpressed, COX20 levels increase . This suggests TMEM177 may stabilize COX20 or protect it from degradation.
TMEM177 associates with newly synthesized COX2 in a COX20-dependent manner, forming a complex that also includes copper chaperones like SCO2. This complex formation appears critical during the early stages of COX2 maturation, particularly at the level of Cu A-site formation . When TMEM177 levels are unbalanced (either through depletion or overexpression), newly synthesized COX2 accumulates in a COX20-associated state, suggesting that TMEM177 promotes the progression of COX2 through its assembly pathway .
TMEM177 plays a facilitatory role in copper delivery to the Cu A-site of COX2, although it does not appear to directly bind or transport copper ions itself. Instead, TMEM177 functions as part of a protein complex that includes COX20, newly synthesized COX2, and metallochaperones such as SCO1 and SCO2, which are directly involved in copper delivery .
The Cu A-site in COX2 is a binuclear copper center critical for electron transfer during the reduction of oxygen to water in the respiratory chain. TMEM177 associates with this assembly complex in a COX20-dependent manner, suggesting it helps stabilize or organize the interaction between COX2 and copper chaperones . When TMEM177 levels are altered, newly synthesized COX2 accumulates in a COX20-associated state, indicating a delay in assembly progression beyond the copper insertion step. This suggests TMEM177 may facilitate copper handover from metallochaperones to COX2, or promote conformational changes in COX2 necessary for copper incorporation .
TMEM177 appears to be conserved across vertebrates, with orthologs identified in various mammalian species, including humans and mice. Interestingly, TMEM177 lacks a clear homolog in yeast, suggesting it represents a more recent evolutionary adaptation in the cytochrome c oxidase assembly pathway .
The absence of a yeast homolog is particularly noteworthy because many components of the mitochondrial respiratory chain assembly machinery are highly conserved from yeast to humans. This suggests that TMEM177 may have evolved to address specific requirements for COX2 maturation in more complex organisms, possibly related to differences in inner mitochondrial membrane organization, mitochondrial protein synthesis regulation, or coordination of nuclear and mitochondrial gene expression .
Sequence comparisons between human and mouse TMEM177 reveal high conservation, particularly in the transmembrane domains and regions predicted to be involved in protein-protein interactions. This conservation underscores the functional importance of these domains and suggests the mechanism by which TMEM177 participates in COX2 assembly is similar across mammalian species .
Expressing recombinant Mouse TMEM177 requires careful optimization due to its nature as a transmembrane protein. Based on published methodologies, the following conditions are recommended:
| Parameter | Recommended Conditions |
|---|---|
| Expression System | HEK-293 cells (mammalian expression system) |
| Vector | Expression vector with His tag or other affinity tag |
| Purification | One-step affinity chromatography |
| Quality Control | Bis-Tris PAGE, anti-tag ELISA, Western Blot, and analytical SEC (HPLC) |
| Expected Purity | >90% for high-quality preparations |
| Storage | -80°C to maintain protein stability |
| Buffer | Custom buffer composition based on experimental needs |
Protein expressed in mammalian cells is particularly advantageous as it ensures reliability for intracellular, secreted, and transmembrane proteins like TMEM177 . The optimized expression system with one-step affinity chromatography provides a balance of yield and purity suitable for most research applications. For specialized applications requiring different tags or expression systems, cell-free protein synthesis (CFPS) has also been used successfully, though typically yielding slightly lower purity (70-80%) .
Studying TMEM177-protein interactions requires specialized approaches suitable for membrane proteins localized to mitochondria. The following methods have proven effective:
Co-Immunoprecipitation (Co-IP):
This approach has successfully identified interactions between TMEM177 and other proteins including COX20, newly synthesized COX2, and SCO2 . When performing Co-IP experiments, use mild detergents (0.5-1% Triton X-100 or digitonin) to solubilize membrane proteins while preserving interactions .
Quantitative Mass Spectrometry:
Quantitative proteomics has been successfully employed to define the TMEM177 interaction network. In published studies, FLAG-tagged proteins were immunoprecipitated, and FLAG/wild-type ratios were determined. Log10-transformed protein ratios were then plotted against corresponding p-values calculated using Student's t-test to identify significant interactions .
Proximity Labeling Techniques:
BioID or APEX2-based approaches can capture transient or weak interactions in the native cellular context, which is particularly valuable for mitochondrial membrane proteins like TMEM177.
Submitochondrial Localization Studies:
Protease protection assays have been used to determine TMEM177's membrane topology and interaction partners. These involve isolating mitochondria in appropriate buffers (such as SEM buffer: 250 mM sucrose, 1 mM EDTA, 10 mM MOPS pH 7.2), followed by membrane fractionation and analysis by SDS-PAGE and Western blotting .
Based on published methodologies, the following approach has proven effective for TMEM177 knockdown:
siRNA-mediated Knockdown:
siRNA sequence: 5′-GACACUUGUUCCGAAUCAA-3′ at 50 nM concentration
Transfection reagent: Lipofectamine RNAiMAX
Cell density: 500,000 cells/25 cm²
Analysis timepoint: 72 hours post-transfection for optimal effect
Experimental Controls:
Include non-targeting siRNA control
Validate knockdown efficiency by Western blot or qRT-PCR
Include COX20 knockdown (5′-GGAGGGUUUAUCUUGGUGA-3′, 33 nM) as a functional comparison
Phenotypic Analysis:
When evaluating TMEM177 knockdown effects, researchers should assess:
COX20 abundance (by Western blot)
Accumulation of newly synthesized COX2 in COX20-associated state
Impact on cytochrome c oxidase assembly
Effects on mitochondrial respiration capacity
Research has shown that TMEM177 depletion leads to reduced COX20 levels, demonstrating their functional relationship . Careful experimental design with appropriate controls enables reliable assessment of TMEM177's specific roles in COX2 maturation and cytochrome c oxidase assembly.
For studying TMEM177's localization and function, proper mitochondrial isolation is essential. The following protocol has been successfully employed:
Cell Preparation:
Harvest cells and wash with appropriate buffer
Homogenize in isolation buffer (typically 250 mM sucrose, 1 mM EDTA, 10 mM MOPS pH 7.2)
Differential Centrifugation:
Submitochondrial Fractionation:
Protease Protection Assay:
Treat intact mitochondria, mitoplasts, or sonicated mitochondria with proteases
Analyze TMEM177 susceptibility to proteolysis to determine membrane topology
Sample Analysis:
This methodology allows for comprehensive analysis of TMEM177's submitochondrial localization and its interactions with other proteins involved in cytochrome c oxidase assembly.
While TMEM177 is dispensable for cytochrome c oxidase activity under normal conditions, it plays an important regulatory role in the assembly process. Research has demonstrated several key aspects of TMEM177's impact on cytochrome c oxidase:
Assembly Promotion: TMEM177 promotes assembly of COX2 specifically at the level of Cu A-site formation, a critical step in cytochrome c oxidase maturation .
COX20 Stabilization: The amount of TMEM177 directly influences COX20 abundance - knockdown of TMEM177 leads to reduced COX20 levels, while overexpression increases COX20 levels .
Assembly Intermediate Regulation: When TMEM177 levels are unbalanced (either through depletion or overexpression), newly synthesized COX2 accumulates in a COX20-associated state. This suggests TMEM177 facilitates progression of COX2 through its assembly pathway beyond the initial COX20 interaction stage .
Copper Center Formation: By participating in complex formation with metallochaperones like SCO2, TMEM177 appears to facilitate the critical process of copper delivery to the Cu A-site of COX2, which is essential for cytochrome c oxidase function .
These observations indicate that TMEM177 serves as an accessory factor that optimizes the efficiency of COX2 maturation rather than being absolutely required for cytochrome c oxidase activity. Its role becomes particularly important for maintaining optimal assembly rates, especially under conditions that may stress the mitochondrial assembly machinery.
Researchers working with TMEM177 should be prepared to address several technical challenges inherent to mitochondrial membrane protein studies:
Protein Solubility: As a transmembrane protein, TMEM177 requires appropriate detergents for solubilization without disrupting its native structure or interactions. Optimization of detergent type and concentration is essential for successful extraction and analysis .
Antibody Specificity: Commercial antibodies against TMEM177 may vary in specificity and performance across applications. Validation using knockdown or knockout controls is strongly recommended. Alternatively, epitope tagging (His, FLAG, etc.) can facilitate detection of recombinant TMEM177 .
Functional Redundancy: While TMEM177 is important for optimizing COX2 assembly, it is dispensable for cytochrome c oxidase activity under normal conditions. This suggests potential compensatory mechanisms that may mask phenotypes in knockdown experiments, requiring careful experimental design and sensitive assays to detect subtle functional changes .
Mitochondrial Isolation Quality: The quality of mitochondrial preparations significantly impacts experiments involving TMEM177. Optimized isolation protocols that preserve mitochondrial integrity and membrane protein complexes are essential for reliable results .
Expression System Selection: When expressing recombinant TMEM177, the choice between mammalian expression systems (>90% purity) and cell-free protein synthesis (70-80% purity) involves trade-offs between yield, purity, and functional attributes that should be considered based on experimental requirements .
By anticipating these challenges and implementing appropriate methodological adaptations, researchers can successfully navigate the technical complexities of TMEM177 studies and generate reliable, reproducible results.